BETA BLOCKERS

Course overview

BETA-BLOCKERS, AS A CLASS OF DRUGS, ARE PRIMARILY USED TO TREAT CARDIOVASCULAR DISEASES AND OTHER CONDITIONS. BETA-BLOCKERS ARE INDICATED AND HAVE FDA APPROVAL FOR THE TREATMENT OF TACHYCARDIA, HYPERTENSION, MYOCARDIAL INFARCTION, CONGESTIVE HEART FAILURE, CARDIAC ARRHYTHMIAS, CORONARY ARTERY DISEASE, HYPERTHYROIDISM, ESSENTIAL TREMOR, AORTIC DISSECTION, PORTAL HYPERTENSION, GLAUCOMA, MIGRAINE PROPHYLAXIS, AND OTHER CONDITIONS. THEY ARE ALSO USED TO TREAT LESS COMMON CONDITIONS SUCH AS LONG QT SYNDROME AND HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICOLOGY, AND MONITORING OF THE BROAD ARRAY OF PHYSIOLOGICAL POSSIBILITIES WHEN USING BETA-BLOCKERS IN THE CLINICAL SETTING.